MCG is Clinically Applied to Evaluate Myocardial Ischemic Function in Patients With Stable Coronary Artery Disease

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNanhai Hospital, Guangdong Provincial People's Hospital

About this trial

The objective of this observational study is to evaluate the diagnostic effectiveness of magnetocardiography (MCG) in patients with stable coronary artery disease (SCAD) and compare it with coronary CTA (CCTA). Additionally, the study aims to determine the most suitable diagnostic index for MCG. The primary question it seeks to address is whether MCG or MCG combined with CCTA can be utilized to guide the clinical application of percutaneous coronary intervention (PCI) for coronary heart disease.

Eligibility criteria

Qualifiers

Age ≥18 years old.

Stable coronary artery disease patients with a coronary CTA stenosis degree of 30% to 90%.

Sign informed consent.

Disqualifiers

Patients diagnosed with acute coronary syndrome.

Patients diagnosed with hypertrophic cardiomyopathy.

Patients diagnosed with dilated cardiomyopathy.

Patients with complex arrhythmias, such as frequent atrial premature beats, ventricular premature beats, and complete bundle branch block.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed